620 related articles for article (PubMed ID: 19099350)
1. Management of metastatic renal cell carcinoma: current trends.
Mohammed A; Shergill I; Little B
Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
3. Conclusion and future directions.
Samlowski WE; Vogelzang NJ
Cancer J; 2008; 14(5):330-2. PubMed ID: 18836339
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
Pantuck AJ; Belldegrun AS; Figlin RA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
[TBL] [Abstract][Full Text] [Related]
5. Debulking nephrectomy in metastatic renal cancer.
Flanigan RC
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic developments in renal cell cancer.
Prenen H; Gil T; Awada A
Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
Halbert RJ; Figlin RA; Atkins MB; Bernal M; Hutson TE; Uzzo RG; Bukowski RM; Khan KD; Wood CG; Dubois RW
Cancer; 2006 Nov; 107(10):2375-83. PubMed ID: 17048248
[TBL] [Abstract][Full Text] [Related]
8. Presurgical therapy in metastatic renal cell carcinoma.
Jonasch E
Expert Rev Anticancer Ther; 2007 Jan; 7(1):73-8. PubMed ID: 17187521
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
Margulis V; Matin SF; Wood CG
Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for renal cell cancer.
Yang JC; Childs R
J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
[TBL] [Abstract][Full Text] [Related]
12. Nephrectomy for metastatic renal cell carcinoma and surgery for distant metastases.
Van Poppel H; Baert L
Acta Urol Belg; 1996 May; 64(2):11-7. PubMed ID: 8701800
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for renal cell carcinoma.
Belldegrun A; Figlin R; Danella J; deKernion J
Semin Urol; 1992 Feb; 10(1):23-7. PubMed ID: 1565900
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment of metastatic renal cell carcinoma.
Mickisch GH
Expert Rev Anticancer Ther; 2002 Dec; 2(6):681-5. PubMed ID: 12503214
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma: current status and emerging therapies.
Nelson EC; Evans CP; Lara PN
Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic options in metastatic renal carcinoma].
Fernández Aparicio T; Miñana López B; Carrero V; Caballero J; Vazquez S; Calahorra L; Leiva O
Actas Urol Esp; 1992 Jul; 16(7):529-39. PubMed ID: 1442223
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome.
Machado NO; Chopra P
JOP; 2009 Jul; 10(4):413-8. PubMed ID: 19581746
[TBL] [Abstract][Full Text] [Related]
18. [Surgical treatment of late metastases of kidney cancer].
Matveev VB; Gurariĭ LL; Began-Bogatskiĭ KM
Urol Nefrol (Mosk); 1999; (2):51-2. PubMed ID: 12434447
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of endovascular treatment of metastatic renal cell cancer].
Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
[TBL] [Abstract][Full Text] [Related]
20. The failure of infarction and/or nephrectomy in stage IV renal cell cancer to influence survival or metastatic regression.
Flanigan RC
Urol Clin North Am; 1987 Nov; 14(4):757-62. PubMed ID: 3314066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
